Company page

Celularity Inc.

Celularity Inc. (ticker: CELU) is a public company based in the United States, with a market capitalization of approximately $21.8 million. The company focuses on developing innovative therapies derived from placental cells. Celularity aims to advance its research and product offerings in the field of regenerative medicine.